Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

导出 LinkOut

翻译打印收藏纠错

作者： Louis,de Mestier ^[1] ; Clarisse,Dromain ; Gaspard,d'Assignies ; Jean-Yves,Scoazec ; Nathalie,Lassau ; Rachida,Lebtahi ; Hedia,Brixi ; Emmanuel,Mitry ; Rosine,Guimbaud ; Frédéric,Courbon ; Michèle,d'Herbomez ; Guillaume,Cadiot

作者单位： Department of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France Department of Radiology, Institut Gustave-Roussy, Villejuif, France Department of Radiology, Beaujon University Hospital, Clichy, France Department of Pathology, Edouard-Herriot Hospital, Lyon, France Integrated Research Cancer Institute in Villejuif, UMR 8081, Paris-Sud University, Institut Gustave-Roussy, Villejuif, France Department of Nuclear Medicine, Beaujon University Hospital, Clichy, France Department of Medical Oncology, René-Huguenin Hospital, Institut Curie, Saint-Cloud, France Department of Digestive Oncology, Institut Claudius-Regaud and Toulouse University Hospital, Toulouse, France Department of Nuclear Medicine, Institut Claudius-Regaud, Toulouse, France Department of Biology and Pathology, Lille University Hospital, Lille, France. ^[1]

关键词 CT scan MRI biomarker contrast-enhanced imaging evaluation isotopic imaging neuroendocrine tumors prognosis progression response targeted therapies ultrasonography

主题词动物(Animals);疾病恶化(Disease Progression);胃肠肿瘤(Gastrointestinal Neoplasms);人类(Humans);分子靶向治疗(Molecular Targeted Therapy);神经内分泌瘤(Neuroendocrine Tumors)

DOI 10.1530/ERC-13-0365

PMID 24351682

发布时间 2014-04-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交